Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase

Simultaneous inhibition of multiple kinases has been suggested to provide synergistic effects on inhibition of tumour growth and resistance. This study describes the design, synthesis and evaluation of 18 compounds incorporating a pyrrolo[2,3-d]pyrimidine scaffold for dual inhibition of epidermal gr...

Full description

Bibliographic Details
Main Authors: Sonali Kurup, Bradley McAllister, Pavlina Liskova, Trusha Mistry, Anthony Fanizza, Dan Stanford, Jolanta Slawska, Ulrich Keller, Alexander Hoellein
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2017.1376666
_version_ 1818334214648496128
author Sonali Kurup
Bradley McAllister
Pavlina Liskova
Trusha Mistry
Anthony Fanizza
Dan Stanford
Jolanta Slawska
Ulrich Keller
Alexander Hoellein
author_facet Sonali Kurup
Bradley McAllister
Pavlina Liskova
Trusha Mistry
Anthony Fanizza
Dan Stanford
Jolanta Slawska
Ulrich Keller
Alexander Hoellein
author_sort Sonali Kurup
collection DOAJ
description Simultaneous inhibition of multiple kinases has been suggested to provide synergistic effects on inhibition of tumour growth and resistance. This study describes the design, synthesis and evaluation of 18 compounds incorporating a pyrrolo[2,3-d]pyrimidine scaffold for dual inhibition of epidermal growth factor receptor kinase (EGFR) and aurora kinase A (AURKA). Compounds 1–18 of this study demonstrate nanomolar inhibition of EGFR and micromolar inhibition of AURKA. Compounds 1–18 allow for a structure–activity relationships (SAR) analysis of the 4-anilino moiety for dual EGFR and AURKA inhibition. Compound 6, a 4-methoxyphenylpyrrolo[2,3-d]pyrimidin-4-amine, demonstrates single-digit micromolar inhibition of both AURKA and EGFR and provides evidence of a single molecule with dual activity against EGFR and AURKA. Compound 2, the most potent inhibitor of EGFR and AURKA from this series, has been further evaluated in four different squamous cell head and neck cancer cell lines for downstream effects resulting from AURKA and EGFR inhibition.
first_indexed 2024-12-13T14:03:59Z
format Article
id doaj.art-b3467f7afdca4bd8a9c2e7c1bf2bc9ed
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-13T14:03:59Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-b3467f7afdca4bd8a9c2e7c1bf2bc9ed2022-12-21T23:42:39ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742018-01-01331748410.1080/14756366.2017.13766661376666Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinaseSonali Kurup0Bradley McAllister1Pavlina Liskova2Trusha Mistry3Anthony Fanizza4Dan Stanford5Jolanta Slawska6Ulrich Keller7Alexander Hoellein8Roosevelt UniversityRoosevelt UniversityRoosevelt UniversityRoosevelt UniversityHarper CollegeHarper CollegeTechnische Universität MünchenTechnische Universität MünchenTechnische Universität MünchenSimultaneous inhibition of multiple kinases has been suggested to provide synergistic effects on inhibition of tumour growth and resistance. This study describes the design, synthesis and evaluation of 18 compounds incorporating a pyrrolo[2,3-d]pyrimidine scaffold for dual inhibition of epidermal growth factor receptor kinase (EGFR) and aurora kinase A (AURKA). Compounds 1–18 of this study demonstrate nanomolar inhibition of EGFR and micromolar inhibition of AURKA. Compounds 1–18 allow for a structure–activity relationships (SAR) analysis of the 4-anilino moiety for dual EGFR and AURKA inhibition. Compound 6, a 4-methoxyphenylpyrrolo[2,3-d]pyrimidin-4-amine, demonstrates single-digit micromolar inhibition of both AURKA and EGFR and provides evidence of a single molecule with dual activity against EGFR and AURKA. Compound 2, the most potent inhibitor of EGFR and AURKA from this series, has been further evaluated in four different squamous cell head and neck cancer cell lines for downstream effects resulting from AURKA and EGFR inhibition.http://dx.doi.org/10.1080/14756366.2017.1376666Pyrrolo[2,3-d]pyrimidinesaurora kinase inhibitorsepidermal growth factor receptor kinase inhibitors
spellingShingle Sonali Kurup
Bradley McAllister
Pavlina Liskova
Trusha Mistry
Anthony Fanizza
Dan Stanford
Jolanta Slawska
Ulrich Keller
Alexander Hoellein
Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
Journal of Enzyme Inhibition and Medicinal Chemistry
Pyrrolo[2,3-d]pyrimidines
aurora kinase inhibitors
epidermal growth factor receptor kinase inhibitors
title Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
title_full Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
title_fullStr Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
title_full_unstemmed Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
title_short Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
title_sort design synthesis and biological activity of n4 phenylsubstituted 7h pyrrolo 2 3 d pyrimidin 4 amines as dual inhibitors of aurora kinase a and epidermal growth factor receptor kinase
topic Pyrrolo[2,3-d]pyrimidines
aurora kinase inhibitors
epidermal growth factor receptor kinase inhibitors
url http://dx.doi.org/10.1080/14756366.2017.1376666
work_keys_str_mv AT sonalikurup designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT bradleymcallister designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT pavlinaliskova designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT trushamistry designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT anthonyfanizza designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT danstanford designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT jolantaslawska designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT ulrichkeller designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase
AT alexanderhoellein designsynthesisandbiologicalactivityofn4phenylsubstituted7hpyrrolo23dpyrimidin4aminesasdualinhibitorsofaurorakinaseaandepidermalgrowthfactorreceptorkinase